NEW YORK CITY, NY / ACCESS Newswire / February 22, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating whether the board members and senior executives of OneStream, Inc. ("OneStream" or the "Company") (NASDAQ:OS) breached their fiduciary duties in connection with the Company’s proposed take-private transaction led by Hg Capital, with minority participation from General […]

NEW YORK CITY, NY / ACCESS Newswire / February 22, 2026 / Attorney Advertising Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of KDDI Corporation ("KDDI" or "the Company") (OTCMKTS:KDDIY). Investors who purchased KDDI securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site:

NEW YORK CITY, NY / ACCESS Newswire / February 22, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Hims & Hers Health, Inc. ("Hims & Hers" or "the Company") (NYSE:HIMS). Investors who purchased Hims & Hers securities are encouraged to obtain additional information and assist the investigation

NEW YORK CITY, NY / ACCESS Newswire / February 22, 2026 / Attorney Advertising Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cerevel Therapeutics Holdings, Inc. ("Cerevel" or "the Company") (NASDAQ:CERE). Investors who purchased Cerevel securities prior to October 11, 2023, and continue to hold to the present, are

NEW YORK CITY, NY / ACCESS Newswire / February 22, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Arconic Corporation ("Arconic" or "the Company") (NYSE:ARNC). Investors who purchased Arconic securities prior to April 19, 2022, and continue to hold to the present, are encouraged to obtain additional

NEW YORK CITY, NY / ACCESS Newswire / February 22, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against uniQure N.V. ("uniQure" or the "Company") (NASDAQ:QURE).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

NEW YORK CITY, NY / ACCESS Newswire / February 22, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Quanex Building Products Corporation ("Quanex" or "the Company") (NYSE:NX). Investors who purchased Quanex securities prior to December 12, 2024, and continue to hold to the present, are encouraged to

NEW YORK CITY, NY / ACCESS Newswire / February 22, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sharecare Inc. ("Sharecare" or "the Company") (NASDAQ:SHCR). Investors who purchased Sharecare securities prior to May 10, 2023, and continue to hold to the present, are encouraged to obtain additional

NEW YORK CITY, NY / ACCESS Newswire / February 22, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Paysafe Limited ("Paysafe" or the "Company") (NYSE:PSFE).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

NEW YORK CITY, NY / ACCESS Newswire / February 22, 2026 / Attorney Advertising Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of MGP Ingredients, Inc. ("MGP Ingredients" or "the Company") (NASDAQ:MGPI). Investors who purchased MGP Ingredients securities prior to May 4, 2023, and continue to hold to the present,